| Kamala Rose, MD | |
|
1035 116th Ave Ne, Bellevue, WA 98004-4604 | |
| (425) 688-5759 | |
| (425) 688-5101 |
| Full Name | Kamala Rose |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 1035 116th Ave Ne, Bellevue, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205990322 | NPI | - | NPPES |
| 8254559 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 38507 (Washington) | Primary |
| Entity Name | Puget Sound Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801900501 PECOS PAC ID: 2961301882 Enrollment ID: O20040108000594 |
News Archive
Researchers from Illinois State University, North Carolina State University, University of South Carolina, and University of Maryland published a new paper in the Journal of Marketing that examines the impact of moving nutrition labels, typically placed on the back of product packages, to the front.
PowerVision, Inc., a private company developing an accommodating intraocular lens, today announced the closing of the first tranche of its Series D funding round with participation from existing investors Venrock, Johnson & Johnson Development Corp., Medtronic, Advanced Technology Ventures, Lexington Capital and Frazier Healthcare Ventures.
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, Calif.
Ten McGill University researchers received an important boost today, by way of the announcement of $1.7 million in new funding awarded through the Canada Foundation for Innovation's Leaders Opportunity Fund. "CFI investments are critical for our research leaders, to ensure that their research remains innovative and second to none," said Dr. Rima Rozen, Interim Vice-Principal (Research and International Relations) at McGill.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the third quarter and nine months ended September 30, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kamala Rose, MD Po Box 34960, Seattle, WA 98124-1960 Ph: (425) 656-4255 | Kamala Rose, MD 1035 116th Ave Ne, Bellevue, WA 98004-4604 Ph: (425) 688-5759 |
News Archive
Researchers from Illinois State University, North Carolina State University, University of South Carolina, and University of Maryland published a new paper in the Journal of Marketing that examines the impact of moving nutrition labels, typically placed on the back of product packages, to the front.
PowerVision, Inc., a private company developing an accommodating intraocular lens, today announced the closing of the first tranche of its Series D funding round with participation from existing investors Venrock, Johnson & Johnson Development Corp., Medtronic, Advanced Technology Ventures, Lexington Capital and Frazier Healthcare Ventures.
The prostate-specific antigen test, commonly known as the PSA test, is valuable in predicting which men should have biopsies and which are likely to be diagnosed with low-risk prostate cancer, a Mayo Clinic study has found. The findings were released today during a meeting of the North Central Section of the American Urological Association in Rancho Mirage, Calif.
Ten McGill University researchers received an important boost today, by way of the announcement of $1.7 million in new funding awarded through the Canada Foundation for Innovation's Leaders Opportunity Fund. "CFI investments are critical for our research leaders, to ensure that their research remains innovative and second to none," said Dr. Rima Rozen, Interim Vice-Principal (Research and International Relations) at McGill.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the third quarter and nine months ended September 30, 2010.
› Verified 3 days ago
Dr. Stephen I Tilghman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 15325 Se 30th Pl Ste 200, Bellevue, WA 98007 Phone: 425-641-4451 Fax: 425-641-7640 | |
Salma F Gharib, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11511 Ne 10th St, Bellevue, WA 98004 Phone: 425-502-3000 | |
Stephen W Marshall, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Marcus A Trione, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Avenue Ne, Bellevue, WA 98004 Phone: 425-688-5759 Fax: 425-688-5101 | |
Dr. Lawrence Chu, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5623 168th Pl Se, Bellevue, WA 98006 Phone: 425-746-3515 | |
Cory Heidelberger, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 | |
Dr. Benjamin Andrew Savitch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1035 116th Ave Ne, Bellevue, WA 98004 Phone: 425-688-5759 |